Meet Dr. Adam Kirton, a Pediatric Neurologist at Alberta Children’s Hospital and University of Calgary. Here, in a conversation with Dr. Judy Illes, he discusses the visibility of alternative therapies for cerebral palsy and the ethical issues around where families 'place hope’.

This 'Conversations in Neuroethics for Neurodevelopmental disorders' series was created by NeuroDevNet, the Knowledge Translation Core and National Core for Neuroethics. Please visit neuroethicscanada.ca and neurodevnet.ca to find short videos, reference lists and more.

Adam Kirton-CP and Alternative Therapies

The National Core for Neuroethics is an interdisciplinary research group dedicated to tackling the ethical, legal, policy and social implications of frontier technological developments in the neurosciences. Our objective is to align innovations in the brain sciences with societal, cultural and individual human values through high impact research, education and outreach.

The Core’s major research  projects are focused on high impact, high visibility areas including cognitive enhancement, ethics in neurodegeneration and regenerative medicine, international and cross-cultural challenges in brain research, neuroimaging in the private sector, and the ethics of personalized medicine, among others. For an overview of our recent work, please see our most recent Annual Report here.

We are located  at the University of British Columbia Hospital in Vancouver, Canada.


Adam Kirton-CP and Alternative Therapies

Neuroethics Core